Investing
Editor's Top Picks
Your one-stop resource for personal news and tips.
More form Investing
AT&T’s stock could be the top wireless play this earnings season. Here’s why.
AT&T Inc.’s stock presents the best “risk-adjusted upside” as the big wireless companies prepare to…
Vroom, the once-mighty Carvana competitor, will wind down its used-car business
Vroom Inc., once valued at a heady $2.5 billion, said Monday it is winding down…
Morgan Stanley’s new top software pick is a familiar winner
Shares of Salesforce Inc. are up 85% over the past 12 months, but Morgan Stanley…
Opinion: Why Supermicro is mopping up the floor with the competition
Super Micro Computer Inc. appears to be mopping up the floor with the competition in…
Tencent’s Riot Games to cut around 530 jobs, or 11% of its workforce
Videogame maker Riot Games on Monday said it would lay off around 530 employees globally,…
United sees bigger-than-expected first-quarter loss after 737 Max groundings. Here’s why the stock is rallying anyway.
United Airlines Holdings Inc. said it expected to lose more money than expected in the…
Space stock Intuitive Machines climbs ahead of historic commercial moon-landing mission
Shares of space-exploration company Intuitive Machines Inc. climbed 7.3% on Monday as the lunar-landing spotlight…
Solana leads way as large cryptocurrencies fall
All large cryptocurrencies were down during morning trading on Monday, with Solana SOLUSD, -5.48% seeing…
Ericsson says infrastructure investment slump will continue to impact its sales in 2024
Shares in Telefonaktiebolaget LM Ericsson on Tuesday fell on Tuesday after the Swedish telecoms giant…
Marriott Grows Rooms 4.7% in 2023, Above Guidance
By Will Feuer Marriott International grew its tally of rooms around the world by 4.7%…
Amer Sports Sets IPO of 100 Million Shares at $16-$18 a Share
By Chris Wack Amer Sports is launching its initial public offering of 100 million shares,…
Pharvaris Says FDA Lifted Clinical Hold on Application for Deucrictibant
By Denny Jacob Clinical-stage company Pharvaris said the U.S. Food and Drug Administration lifted the…
Cara Therapeutics to Reduce Staff by 50%, Focus Resources
By Will Feuer Cara Therapeutics said it plans to reduce its workforce by about 50%…
ArriVent BioPharma to Sell 8.33 Million Shares at $17-$19 Each in IPO
By Colin Kellaher ArriVent BioPharma plans to sell more than 8.33 million shares at between…
Macy’s Stock Rises After Rejecting Private Equity Buyout. It’s Just the Beginning.
Macy’s rejected an unsolicited $5.8 billion offer to take the department store chain private on…